Ozawal, S.; Kamiya, H.; Tsuzuki, K. Glutamate receptors in the mammalian central nervous system. Prog. Neurobiol. 54:581-618; 1998.

Bettler, B.; Mulle, C. Review: Neurotransmitter Receptors II AMPA and Kainate receptors. Neuropharmacology 34:123-139; 1995.

Wisden, W.; Seeburg, P. H. A complex mosaic of high-affinity kainate receptors in rat brain. J. Neurosci. 13:3582-3598; 1993.

Porter,R. H. P.; Eastwood, S. L.; Harrison, P. J. Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in Schizophrenia. Brain Res. 751:217-231; 1997.

Titze-de Almeida, R.; Lino de Oliveira, C.; Shida, H. W.; Guimarães, F. S.; Del Bel, E. A. Midazolan and the N-methyl-D-aspartate (NMDA) receptor antagonist 2-amino-7-phosphonoheptanoic acid (AP-7) attenuate stress-induced expression of c-fos mRNA in the dentate gyrus. Cell. Mol. Neurobiol. 14:373-380; 1994.

Bartanusz, V.; Aubry, J.-M.; Pagliusi, S.; Jesova, D.; Baffi, J.; Kiss, J. Z. Stress-induced changes in messenger RNA levels of N-methyl-D-aspartate and AMPA receptor subunits in selected regions of the rat hippocampus and hypothalamus. Neuroscience 6:247-252; 1995.

Rosa, M. L. N. M.; Guimarães, F. S.; Pearson, R. C. A.; Del Bel, E. A. Effects of single or repeated restraint stress on GluR1 and GluR2 flip and flop mRNA expression in the hippocampal formation. Brain Res. Bull. 59:117-125; 2002.

Schwendt, M.; Jezova, D. Gene expression of two glutamate receptor subunits in response to repeated stress exposure in rat hippocampus. Cell. Mol. Neurobiol. 20:319-29; 2000.

Padovan, C. M.; De Oliveira, R. M. W.; Deakin, J. F. W.; Guimarães, F. S. Changes in mRNA levels of NR1 receptor in rat hippocampus induced by stress. (submetido)

Eastwood, S. L.; Mcdonald, B.; Burnet, P. W. J.; Beckwith, J. P.; Kerwin, R. W.; Harrison, P. J. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Mol. Brain Res. 29:211-223; 1995.

Eastwood, S. L.; Story, P.; Burnet, P. W. J.; Heath, P.; Harrison, P. J. Differential changes in glutamate receptor subunit messenger RNAs in rat brain after haloperidol treatment. J. Psychopharmacol. 8:196-203; 1994.

Eastwood, S. L.; Porter, R. H. P.; Harrison, P. J. The effect of chronic haloperidol treatment on glutamate receptor subunit (GluR1, GluR2, NR1, KA1, KA2) mRNAs and glutamate binding protein mRNA in the rat forebrain. Neurosci. Lett. 212:163-166; 1996.

Chen, A. C. H.; McDonald, B.; Moss, S. J.; Gurling, H. M. D. Gene expression studies of mRNAs encoding the NMDA receptor subunits NMDAR1, NMDAR2A, NMDAR2B, NMDAR2C, and NMDAR2D following long term treatment with cis and trans flupenthixol as a model for understanding the mode of action of schizophrenia drug treatment. Mol. Brain Res. 54:92-100; 1998.

Chen, A. C. H.; Gurling, H. M. D. D2 dopamine receptor but not AMPA and kainate glutamate receptor genes show altered expression in response to long term treatment with trans- and cis- flupenthixol in the rat brain. Mol. Brain Res. 68:14-21; 1999.

Harrison, P. J.; McLaughlin, D.; Kerwin, R. W. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet, 337:450-452; 1991.

Kerwin, R. W.; Patel, S.; Meldrum, B. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem. Neuroscience, 39:25-32; 1990.

Coyle, J. T. Neurotoxic action of kainic acid. J. Neurochem. 41:1-11; 1983.

Represa, A.; Tremblay, E.; Ben-Ari, Y. Kainate binding sites in the hippocampal mossy fibers: Localization and plasticity. Neuroscience 20:739-748; 1987.

Geddes, J. W.; Monaghan, D. T.; Cotman, C. W.; Lott, I. T.; Kim, R. C.; Chui, H. C. Plasticity of hippocampal circuitry in Alzheimer’s disease. Science 230:1179-1181; 1985.

Geddes, J. W.; Chang Chui, H.; Cooper, S. M.; Lott, I. T.; Cotman, C. W. Density and distribution of NMDA receptors in the human hippocampus in Alzheimer’s disease. Brain Res. 399:156-161; 1986.

Harrison, P. J.; Barton, A. J. L.; Najlerahim, A.; Pearson, R. C. A. Distribution of a kainite/AMPA receptor mRNA in normal and Alzheimer brain. NeuroReport 1:149-152; 1990.

Garcia-Ladona, F. J.; Palacios, J. M.; Probst, A.; Wieser, H. G.; Mengod, G. Excitatory amino acid AMPA receptor mRNA localization in several regions of normal and neurological disease affected human brain. An in situ hybridization histochemistry study. Mol. Brain Res. 21:75-84; 1994.

Pellegrini-Giamprieto, D. E.; Bennett, M. V. L.; Zukin, R. S. AMPA/Kainate receptor gene expression in normal and Alzheimer’s disease hippocampus. Neuroscience 61:41-49; 1994.

Ikonomovic, M. D.; Mizukami, K.; Davies, P.; Hamilton, R.; Sheffield, R.; Armstrong, D. M. The loss of GluR2(3) immunoreactivity precedes neurofibrillary tangle formation in the entorhinal cortex and hippocampus of Alzheimer’s brains. J. Neuropathol. Exp. Neurol. 56:1018-1027; 1997.

Ikonomovic, M. D.; Mizukami, K.; Warde, D.; Sheffield, R.; Hamilton, R.; Wenthold, R. J.; Armstrong, D. M. Distribution of glutamate receptor subunit NMDAR1 in the hippocampus of normal elderly and patients with Alzheimer’s disease. Exp. Neurol. 160:194-204; 1999.

Karreman, M.; Westerink, B. H. C.; Moghaddam, B. Excitatory amino acid receptors in the ventral tegmental area regulate dopamine release in the ventral striatum. J. Neurochem. 67: 601-607; 1996.

Todaka, K.; Ishida, Y.; Kuwahara, I.; Nishimori, T.; Mitsuyama, Y. Cellular distributions of AMPA glutamate receptor subunits in the substantia nigra of a rat model of Parkinson’s disease. J. Brain Sci. 23:213-224; 1997.

Todaka, K.; Ishida, Y.; Kuwahara, I.; Nishimori, T.; Mitsuyama, Y. Cellular distributions of AMPA glutamate receptor subunits in fetal ventral mesencephalon transplants in the dopamine-depleted striatum of a rat. Brain Res. Bull. 47:325-330; 1998.

Pollard, H.; Heron, A.; Moreau, J.; Ben-Ari, Y.; Khrestcatisky, M. Alterations of the GluR-B AMPA receptor flip/flop expression in kainate-induced epilepsy and ischemia. Neuroscience 57:545-554; 1993.

During, M. J.; Spencer, D. D. Extracellular hippocampal glutamate and spontaneous seizures in the conscious human brain. Lancet 341:1607-1610; 1993.

Kamphuis, W.; De Rijk, T. C.; Talamini, L. M.; Lopes da Silva, F. H. Rat hippocampal kindling induces changes in the glutamate receptor mRNA expression patterns in dentate granule neurons. Eur. J. Neurosci. 6:1119-1127; 1994.

Brines, M. L.; Sundaresan, S.; Spencer, D. D.; de Lanerolle, N. C. Quantitative autoradiographic analysis of ionotropic glutamate receptor subtypes in human temporal lobe epilepsy: Up-regulation in reorganized epileptogenic hippocampus. Eur. J. Neurosci. 9:2035-2044; 1997.

Rosa, M. L. N. M.; Jefferys, J. G. R.; Sanders, M. W.; Pearson, R. C. A. Expression of mRNAs encoding flip isoforms of GluR1 and GluR2 glutamate receptors is increased in rat hippocampus in epilepsy induced by tetanus toxin. Epilepsy Res. 36:243-251; 1999.

Choi, D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634; 1988.

Murphy, T. H.; Miyamoto, M.; Sastre, A.; Schnaar, R. L.; Coyle, J. T. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2:1547-1558; 1989.

Tan, S.; Wood, M.; Maher, P. Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J. Neurochem. 71:95-105; 1998.

Hampson, A. J.; Grimaldi, M.; Axelrod, J.; Wink, D. Cannabidiol and (-)delta⁹- tetrahydrocannabinol are neuroprotective antioxidants. Proc. Natl. Acad. Sci. USA 95:8268-8273; 1998.

Wallin, C.; Weber, S. G.; Sandberg, M. Glutathione efflux induced by NMDA and kainate: implications in neurotoxicity. J. Neurochem. 73:1566-1572; 1999.